Showing 6531-6540 of 19355 results for "".
Updates on Food Labeling: Effects Felt from Manufacturers to Consumers
https://reachmd.com/programs/clinicians-roundtable/updates-on-food-labeling-effects-felt-from-manufacturers-to-consumers/314/Michael Jacobson discusses the proposed new food labeling system, and how it will impact all parties involved from pruduction chains to consumers..Hospice patients live longer
https://reachmd.com/programs/clinicians-roundtable/hospice-patients-live-longer/195/Join Dr. Stephen R. Connor, the lead researcher for a study published in the March 2007 issue of the Journal of Pain and Symptom Management, as he discusses how hospice care can prolong the lives of some terminally ill patients.What Every Patient Should Know...
https://reachmd.com/programs/clinicians-roundtable/what-every-patient-should-know/38/Before going into the hospital, Mr. Schubert transforms your impressions of your clinical stay, highlighting mishaps, errors and oversights.Pushing the Envelope in PN Research
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37181/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, discusses how research to help understand different aspects of prurigo nodularis can help develop therapeutics that can be life-changing for patientA Personalized Approach to Complex Psoriasis Cases
https://reachmd.com/programs/frontlines-psoriasis/personalized-approach-complex-psoriasis/39955/Evolving insights into Th1-, Th2-, and Th17-driven inflammation are reshaping the diagnosis and management of patients presenting with mixed psoriasis subtypes. Ryan Quigley sits down with Dr. Jenny Murase to learn more about practical approaches to personalized treatment planning, common clinical pSupporting Patients With ATTR-CM: Preserving Function and Quality of Life
https://reachmd.com/programs/heart-matters/supporting-attr-cm-patients-quality-of-life/49059/For patients newly diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM), it's essential to set realistic expectations and prioritize whole-person care. Dr. Joban Vaishnav, Assistant Professor of Medicine and Director of the Comprehensive Amyloidosis Center at Johns Hopkins Medicine,Counseling Patients on Disease Progression in ATTR-CM
https://reachmd.com/programs/heart-matters/counseling-patients-attr-cm-progression/49060/When transthyretin amyloid cardiomyopathy (ATTR-CM) progresses, an individualized and empathetic approach to patient conversations is key. Hear from Dr. Joban Vaishnav as she shares practical strategies for addressing patient fears while clarifying what progression truly means. Dr. Vaishnav is aUnpacking the Complexity of Psoriatic Arthritis
https://reachmd.com/programs/living-rheum/unpacking-the-complexity-of-psoriatic-arthritis/56346/Psoriatic arthritis is a highly heterogeneous disease with diverse clinical presentations, ranging from mild joint involvement to severe, deforming arthritis and axial disease. Join Dr. Lawrence H. Brent as he explores the varied manifestations and comorbidities that complicate diagnosis and managemModern Approaches to Psoriatic Arthritis Management
https://reachmd.com/programs/living-rheum/modern-approaches-to-psoriatic-arthritis-management/56348/The treatment landscape for psoriatic arthritis has expanded significantly, offering a range of targeted therapies with varying mechanisms of action. Tune in to hear Dr. Lawrence H. Brent discuss how clinicians can individualize treatment decisions based on disease manifestations, comorbidities, andAI-Driven Advances in ATTR-CM Care
https://reachmd.com/programs/heart-matters/ai-advances-attr-cm-care/49058/Artificial intelligence has rapidly advanced disease recognition in transthyretin amyloid cardiomyopathy (ATTR-CM), and its role in guiding treatment selection, predicting progression, and refining prognosis is now being explored. Discover what's next in ATTR-CM care with Dr. Frederick Ruberg, Chief